Literature DB >> 17456003

PLoS Medicine and publication ethics: when is it research?

Mary Ann Baily.   

Abstract

Entities:  

Mesh:

Year:  2007        PMID: 17456003      PMCID: PMC1876424          DOI: 10.1371/journal.pmed.0040169

Source DB:  PubMed          Journal:  PLoS Med        ISSN: 1549-1277            Impact factor:   11.069


× No keyword cloud information.
I read this editorial with interest [1]. The issues discussed under the heading “Is a Program Description a Research Paper?” are closely related to the subject matter of a recently completed Hastings Center project funded by the Agency for Healthcare Research and Quality. The project was carried out by a group of distinguished participants with expertise in medicine, law, nursing, quality improvement methods, research ethics, medical editing and publishing, health services research, and health policy and regulation. It addressed the ethics of using quality improvement (QI) methods to improve health care quality and safety, and we spent considerable time on the vexing question of when (if ever) QI activities meet the regulatory definition of research and should be submitted to an Institutional Review Board (IRB) for ethical review. We also discussed the relationship between publication and IRB review. Our analysis would lead to the same conclusion that was reached in the editorial: that the particular case example was not research and did not require IRB review. Readers might find the report's reasoning on the issues interesting, however—and also useful in assessing other cases. Both the project report [2] and a book of background papers [3] have been published, and they can be downloaded in PDF form at no charge from the Web site of The Hastings Center (http://www.thehastingscenter.org) or the Institute for Healthcare Improvement (http://www.ihi.org).
  2 in total

Review 1.  The ethics of using QI methods to improve health care quality and safety.

Authors:  Mary Ann Baily; Melissa Bottrell; Joanne Lynn; Bruce Jennings
Journal:  Hastings Cent Rep       Date:  2006 Jul-Aug       Impact factor: 2.683

2.  PLoS Medicine's Advisory Group on Publication Ethics.

Authors: 
Journal:  PLoS Med       Date:  2007-02       Impact factor: 11.069

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.